Bavarian Nordic on new capital raising round: Covid-19 was the decisive factor
The recent equity emission was quickly set up at Bavarian Nordic, mainly because the firm plans to power ahead with opportunities arisen during the Covid-19 pandemic. This includes the firm's coronavirus vaccine.
BY ELIZABETH MØNSTED JOHANSEN, TRANSLATED BY NIELSINE NIELSEN
Even though Bavarian Nordic has a list of items on its shopping list after recently gaining more capital on the stock market, one factor in particular necessitated that the capital raising round had to take place exactly now.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
